The Massachusetts Public Health Laboratory is accustomed to strong support from the CDC. Now it is learning to go it alone.

A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...

Most of the state has a "low" level of flu in the latest report by the Massachusetts Department of Public Health.